Listening To-and Learning From-the Voice of the Patient

Patient recruitment represents the biggest challenge in clinical trials. From general patient identification and participation to reducing screen failure rate or limiting patient dropout after enrollment, drug developers face many massive pain points to initiate their clinical trials. Today, all CROs have their own methods for identifying optimal investigator sites and recruiting patients. But how many sponsors, CROs or patient recruitment firms are pausing and asking the patient, "What would make you more likely to join a clinical trial?" People are talking to patients, but how many have asked that simple question? And how many drug developers are considering these insights when developing their clinical trial protocol?